The single-agent Bcl-2 inhibitor ABT-199 (GDC-0199) in patients with elapsed/refractory (R/R) non-Hodgkin lymphoma (NHL): Responses observed in all mantle cell lymphoma (MCL) patients Meeting Abstract
| Authors: | Davids, M. S.; Seymour, J. F.; Gerecitano, J. F.; Kahl, B. S.; Pagel, J. M.; Wierda, W. G.; Anderson, M. A.; Rudersdorf, N. K.; Gressick, L. A.; Montalvo, N. P.; Yang, J.; Busman, T. A.; Dunbar, M.; Cerri, E.; Enschede, S. H.; Humerickhouse, R. A.; Roberts, A. W. |
| Abstract Title: | The single-agent Bcl-2 inhibitor ABT-199 (GDC-0199) in patients with elapsed/refractory (R/R) non-Hodgkin lymphoma (NHL): Responses observed in all mantle cell lymphoma (MCL) patients |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385003425 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.1789.1789 |
| Notes: | Meeting Abstract: 1789 -- Source: Wos |
